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Abstract
Porcine circovirus type 2 (PCV2) is the primary causative agent of porcine circovirus-associated diseases (PCVAD). Three
major PCV2 genotypes (PCV2a, PCV2b, and PCV2d) have been identified globally. Despite their worldwide distribution, the
prevalence and genetic evolution of PCV2 in Belgium has not previously been determined. In this study, 319 samples from
animals suffering from diseases likely to be associated with PCV2 were collected from 2009 to 2018 and analysed by virus
titration. The overall prevalence of PCV2 in PCVAD-suspected cases was 15.7 per cent (50/319). The phylogenetic analysis
demonstrated that at least three genotypes (PCV2a, PCV2b, and PCV2d) circulated in Belgium from 2009 till 2018, and that
PCV2 evolved from PCV2a to PCV2b and from PCV2d-1 to PCV2d-2. Sequence comparison among the forty-three PCV2 iso-
lates showed that they had 89.7–100 per cent nucleotide-sequence and 88.5–100 per cent amino-acid-sequence identities.
Three amino acid sites were under positive selection. Three-dimensional analysis of genotype-specific amino acids revealed
that most of the mutations were on the outside of the cap protein with a few conserved mutations present on the inner
side. Mutations toward more basic amino acids were found on the upper and tail parts of two connecting capsid proteins
which form one big contact region, most probably involved in receptor binding. The lower part was relatively conserved.
This polarity change together with the formation of an extruding part drive the virus to a more efficient GAG receptor
binding. Taken together, these results showed a genotype shift from PCV2a to PCV2b and later on from PCV2d-1 to PCV2d-2,
and a PCV2 evolution toward a better receptor binding capacity.
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1. Introduction
Porcine circovirus type 2 (PCV2) is one of the most widespread
viruses that cause economically relevant infections in swine.
After its first identification in the late 1990s, PCV2 is linked
with a variety of disease manifestations, such as postweaning
multi-systemic wasting syndrome (PMWS), porcine dermatitis
and nephropathy syndrome (PDNS), porcine respiratory disease
complex (PRDC), and reproductive failure (Allan 1998; Rosell
et al. 2000; Kim, Chung, and Chae 2003; Madson and Opriessnig
2011). All these diseases are collectively termed porcine
circovirus-associated diseases (PCVAD) (Opriessnig, Meng, and
Halbur 2007). Retrospective serological studies performed on
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archived samples confirmed PCV2 infections from 1962 in
Germany, 1969 in Belgium, 1970 in the UK, 1973 in Ireland, and
1985 in Spain and Canada (Magar, Mu¨ller, and Larochelle 2000;
Walker et al. 2000; Sanchez, Nauwynck, and Pensaert 2001a;
Rodriguez-Arrioja et al. 2003; Grierson et al. 2004; Jacobsen et al.
2009). This demonstrated that PCV2 circulated years prior to its
identification.
PCV2 belongs to the Circovirus genus of the family
Circoviridae. It is an icosahedral and non-enveloped DNA virus,
with a diameter of only 17 nm. The single-stranded circular
PCV2 genome is comprised of 1,766–8 nucleotides (nt) (Guo et al.
2010). It contains two major open reading frames (ORFs): ORF1
encodes two replication-associated proteins (rep and rep0),
which is essential for the multiplication of the PCV2 genome
but absent in the assembled virion; ORF2 encodes a viral capsid
protein (cap), which is the only structural protein. The capsid
protein determines the antigenicity and virulence of PCV2
(Hamel, Lin, and Nayar 1998; Nawagitgul et al. 2000; Lefebvre
et al. 2008; Saha et al. 2012b). Mutation of one or two amino
acids in the cap may affect the virulence and pathogenicity of
PCV2 (Huang et al. 2011; Saha et al. 2012a). In addition, ORF2
alone can serve as a phylogenetic and epidemiologic marker for
comparative analysis of PCV2 (Olvera, Cortey, and Segale´s 2007).
Based on phylogenetic analysis of PCV2 genomic or ORF2
sequences, PCV2 can be divided into six subtypes (PCV2a–f).
PCV2a and PCV2b have been documented worldwide (Segales
et al. 2008). PCV2a was the most prevalent genotype until ap-
proximately 2003 while PCV2b became the predominant one af-
ter 2004 (Segales, Kekarainen, and Cortey 2013). This indicates
an obvious genotype shift from PCV2a to PCV2b, which was de-
scribed in several countries (Carman et al. 2006; Cheung et al.
2007; Dupont et al. 2008; Timmusk et al. 2008; Wiederkehr et al.
2009; Cortey et al. 2011; Segales, Kekarainen, and Cortey 2013).
This shift on genotype prevalence coincided with the advent of
the most severe outbreaks of PCVAD. However, under experi-
mental conditions, the virulence of PCV2a and PCV2b does not
differ significantly (Opriessnig et al. 2008; Saha et al. 2010).
PCV2c was initially detected in archived swine serum samples
in Denmark, and has recently been found in a feral pig in Brazil
(Dupont et al. 2008; Franzo et al. 2015). However, this genotype
is likely of minor importance. The origin of PCV2d strains can be
traced back to 1998 in Switzerland and is now widespread in
many countries, suggesting a genotype shift from PCV2b to
PCV2d (Wei et al. 2013; Xiao, Halbur, and Opriessnig 2015; Kwon
et al. 2017; Ramos et al. 2017; Thangthamniyom et al. 2017).
PCV2d is divided into two subclades, PCV2d-1 and PCV2d-2
(Xiao, Halbur, and Opriessnig 2015). The majority of PCV2d-1
strains were circulating during 1999–2011 while PCV2d-2 was
first identified in 2006, indicating that PCV2d-1 is a possible an-
cestor of PCV2d-2 (Xiao, Halbur, and Opriessnig 2015). The fifth
genotype, PCV2e, was first discovered in Mexican pigs and then
in the USA in a retrospective study, with the earliest sequence
dating back to 2006 (Harmon et al. 2015; Davies et al. 2016). The
last genotype, PCV2f, was first identified in China and is also
present in Croatia, India, and Indonesia (Bao et al. 2018).
In Belgium, the presence of PCV2 was demonstrated in 1969
based on a retrospective serological analysis of PCV2 antibodies
in domestic and feral pig populations (Sanchez, Nauwynck, and
Pensaert 2001a). Large PMWS outbreaks have never been de-
scribed in Belgium (Labarque et al. 2000; Meerts et al. 2004). It is
thought that the use of Pie´train boars for the production of hy-
brid fattening pigs forms the basis of this low susceptibility.
Recent work has demonstrated a more efficient uptake and dis-
integration of PCV2 by monocytes from purebred Pie´train than
those from purebred Landrace and Large White, which may in
part explain this better resistance (Wei et al. 2018). Until now,
only four Belgian strains were isolated from PMWS-affected pig-
lets: strains 1206 and VC2002-K39 were identified as PCV2b,
strain VC2002-K2 as PCV2d-1 (originally identified as PCV2b
based on the old classification system), and strain 4D4 as a re-
combinant strain of VC2002-K2 and VC2002-K39 (Meerts et al.
2004, 2005; Lefebvre et al. 2008, 2009; Saha et al. 2014; Xiao,
Halbur, and Opriessnig 2015). Despite continuous reports of
newly emerging strains and global genotype shifts, there was
little information available regarding the molecular epidemiol-
ogy and evolution of PCV2 in Belgium. The objectives of this
study were to examine the prevalence and genetic evolution of
PCV2 in Belgium from 2009 till 2018, and to find the driving force
behind PCV2 evolution by analyzing the amino acid differences.
2. Materials and methods
2.1 Sample collection
A total of 319 samples (lungs, kidneys, spleen, lymph nodes, se-
rum, or a mix of organs) were collected from unthrifty pigs with
clinical signs of PCVAD in different regions of Belgium from
2009 to 2018. These samples were submitted for diagnostic
analysis to the Laboratory of Virology, Faculty of Veterinary
Medicine, Ghent University. A piece of the organ samples was
homogenized for virus titration and DNA extraction, and the
rest of the samples were stored at 70 C.
2.2 Virus isolation and titration
Twenty per cent (w/v) suspensions of each tissue sample or
pools were made in cold PBS. Afterward, the PCV2 titers were
determined by virus titration on PK-15 cells as described else-
where (Sanchez et al. 2001b). The virus titers were expressed as
log10TCID50/g of tissue (TCID50 ¼ tissue culture infectious dose
with 50% endpoint). Samples were categorized into three groups
with high (4.5 log10TCID50/g), medium (3–4.5 log10TCID50/g),
and low (3 log10TCID50/g) virus titers according to previously
defined criteria (Sanchez et al. 2004). The detection limit of this
technique was 101.7 TCID50/g tissue (Saha et al. 2011).
2.3 DNA extraction, PCR, and sequencing
Total DNA was extracted from tissue homogenates or serum
using QIAamp Cador Pathogen mini kit (Qiagen) following the
manufacturer’s instructions. The viral DNA extracted from
PCV2 strain 1121 virus stock and double distilled water were
used as positive and negative controls during PCR analysis,
respectively. To amplify the ORF2 gene, a conventional PCR as-
say was performed using two primer pairs (ORF2-fw: 50-gcgca
cttcttttcgttttcag-30, ORF2-rev: 50-gaatgcggccgcttatcacttcgtaatg
gtttttattattca-30; pgPCV2-fw: 50-ggctgtggcctttgktac-30, pgPCV2-
rev: 50-tgtrgaccacgtaggcctcg-30) (Lefebvre et al. 2008; Wei et al.
2018). The PCR reaction (25 ml) contained 5 ml of 5  PCR buffer,
0.2 ml of 100 mM dNTPs, 1 ml of 10 mM primers each, 5 ml of DNA
template, 0.5 ml of Herculase II fusion DNA polymerase, and
12.3 ml water. The thermal cycling programme for the PCR reac-
tion was 94 C for 2 min, then 30 cycles of 94 C for 15 s, 54 C for
30 s, and 68 C for 1 min (ORF2-fw/rev) or for 2 min (pgPCV2-fw/
rev), followed by 68 C for 10 min. The amplification products
were examined by agarose gel electrophoresis and were visual-
ized by ethidium bromide staining and UV light. The amplicons
were sent to GATC (Constance, Germany) for Sanger sequenc-
ing. The sequences of the DNA fragments were then assembled
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using EditSeq programme of the DNASTAR version 7.0
(DNASTAR Inc., Madison, WI, USA).
2.4 Bioinformatics analysis
Forty-three ORF2 nucleotide sequences obtained in this study
and twenty-nine published PCV2 ORF2 sequences available in
GenBank (Supplementary Table S1) were included in the phylo-
genetic analysis. All sequences were aligned using the Clustal
W method of the MegAlign programme of the DNASTAR version
7.0. Nucleotide and amino acid sequence similarities were ana-
lysed based on the aligned dataset. A phylogenetic tree was
constructed using the neighbour-joining method in MEGA 7
software (Kumar, Stecher, and Tamura 2016). Reliability of the
neighbour-joining tree was calculated using 1,000 bootstrap rep-
licates. Sequences obtained were deposited in GenBank.
2.5 Selection pressure analysis
An analysis of selection pressure on the cap protein was evalu-
ated using different methods in the Datamonkey (http://www.
datamonkey.org), based on the ratios between non-
synonymous and synonymous substitution rates (dN-dS) (Pond
and Frost 2005). Pervasive and episodic diversifying/purifying
selection was estimated using single-likelihood ancestor count-
ing (SLAC), fixed effects likelihood (FEL), mixed effects model of
evolution (MEME), and fast unconstrained Bayesian approxima-
tion (FUBAR) (Pond and Frost 2005; Murrell et al. 2012, 2013). The
positive signals were accepted when the P-value was below 0.1
in SLAC, FEL, and MEME and when the posterior probability
(Post. Pr.) was above 0.9 in FUBAR. Sites were assumed to be
under positive selection pressure when the positive signals
were detected by at least two methods.
2.6 Three-dimensional (3D) mapping of amino acids in
the PCV2 cap protein
The accurate 3D structures of PCV2 cap protein of different gen-
otypes were predicted using iterative threading assembly re-
finement (I-TASSER) server (https://zhanglab.ccmb.med.umich.
edu/I-TASSER/) based on the sequence of a PCV2a strain (Fh17;
GenBank no. AY322004), a PCV2b strain (1206; GenBank no.
EF990644), and a PCV2d strain (K2; GenBank no. EF990645)
(Zhang 2008; Roy, Kucukural, and Zhang 2010; Yang et al. 2015).
The structures of cap protein were displayed with PyMOL
software (South San Francisco, CA, USA).
3. Results
3.1 Percentage of infectious PCV2-positive cases in
Belgium from 2009 till 2018
The total number of collected cases and virus isolation positive
cases of each year are shown in Table 1. Of the 319 clinical sam-
ples, 50 samples (15.7%) were positive for PCV2 by virus titra-
tion. The total samples were then categorized by virus titer
(log10TCID50/g) (Sanchez et al. 2004). Eight per cent of the sam-
ples (25/319) contained large amounts of infectious PCV2 (4.5
log10TCID50/g), 1 per cent of the samples (3/319) contained mod-
erate amounts of infectious PCV2 (3–4.5 log10TCID50/g), 7 per
cent of the samples (22/319) contained low amounts of infec-
tious PCV2 (3 log10TCID50/g), and 84 per cent of the samples
(269/319) were negative for PCV2 isolation.
3.2 Sequencing of PCV2 ORF2
A total of forty-three samples were subjected to DNA extraction
and PCR amplification of the ORF2 gene. The distribution of
these PCR-examined samples in each year is shown in Table 1.
Sixteen PCV2 isolates from 2009 were randomly selected for fur-
ther PCR analysis from the twenty-six PCV2-titration positive
cases due to a relatively large sample size; all PCV2 isolates
from 2010 till 2017 (twelve isolates in 2010, four isolates in 2009,
four isolates in 2010, four isolates in 2013 and zero isolate in
2014–7) were analyzed by PCR; three out of six serum samples
collected in 2018 that were PCR positive were further se-
quenced. The detailed information of these PCR-examined sam-
ples is shown in Table 2, including the code, year of isolation,
tissue origin, PCV2 titer, and GenBank accession number. The
complete ORF2 sequences were 702 or 705 base pairs (bp) in
length.
3.3 Phylogenetic and homology analyses of PCV2 ORF2
sequences
Genetic and phylogenetic analyses were performed using ORF2
sequences of forty-three Belgian PCV2 isolates and twenty-nine
reference sequences deposited in GenBank by neighbour-
joining method. The phylogenetic tree showed that the forty-
three PCV2 sequences obtained could be classified into three
distinct genotypes (Fig. 1). Three of the forty-three (7%) PCV2
isolates belonged to genotype 2a, thirty-one of the forty-three
(72%) isolates to genotype 2b, and nine of the forty-three (21%)
Table 1. Number of total collected samples, PCV2 isolation-positive cases, PCR-examined cases, and PCV2 genotypes identified each year in
319 samples collected from 2009 to 2018 in Belgium.
Year Total collected Virus isolation positive (%) PCR examined PCV2a PCV2b PCV2d
PCV2d-1 PCV2d-2
2009 141 26 (18.4%) 16/26 3 12 1 0
2010 104 12 (11.5%) 12/12 0 7 5 0
2011 29 4 (13.8%) 4/4 0 4 0 0
2012 18 4 (22.2%) 4/4 0 4 0 0
2013 7 4 (57.1%) 4/4 0 4 0 0
2014 3 0 0 0 0 0 0
2015 7 0 0 0 0 0 0
2016 1 0 0 0 0 0 0
2017 3 0 0 0 0 0 0
2018 6 0 3 0 0 0 3
Total 319 50 (15.7%) 43 3 31 6 3
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isolates to genotype 2d. PCV2c, PCV2e, and PCV2f genotypes
were not detected in the sample set.
The genotype distribution of the forty-three Belgian PCV2
isolates from 2009 till 2018 is listed in Table 1. All three sam-
ples of PCV2a genotype were collected in 2009. Two of them
clustered with an isolate in Canada (GenBank no. AF109398),
while one of them clustered with an isolate from France in
2003 (GenBank no. AY322004). PCV2b was the most common
genotype found from 2009 to 2013, with relatively limited ge-
netic diversity. PCV2d formed an independent cluster which
was further subdivided into two separate subclades: PCV2d-1
and PCV2d-2. Interestingly, PCV2d-1 isolates were found in
2009 (1/6) and in 2010 (5/6), while in 2018 all PCV2d sequen-
ces clustered in the PCV2d-2 clade (3/3). Furthermore, one
strain 10V009 from the PCV2d-1 clade clustered with the
VC2002-K2, the first isolated Belgian PCV2d-1 strain (Meerts
et al. 2004; Saha et al. 2012b; Xiao, Halbur, and Opriessnig
2015).
The length of the ORF2 of PCV2a and PCV2b was 702 bp,
while that of PCV2d was 705 bp resulting in an additional amino
acid, lysine, at the 30-terminus of the capsid protein. Pairwise-
sequence comparisons revealed that the complete ORF2
sequences of forty-three PCV2 isolates shared 89.7–100 per cent
nucleotide sequence and 88.5–100 per cent amino acid sequence
identities. For each genotype, the homology of nucleotide and
amino acid sequences were as follows: for the PCV2a isolates
(n¼ 3): 94.9–99.9 per cent and 95.4–100 per cent; for the PCV2b
isolates (n¼ 31): 95.2–100 per cent and 94–100 per cent, and for
the PCV2d isolates (n¼ 9): 97.7–100 per cent and 97.0–100 per
cent (Table 3). The PCV2d sequences exhibited the lowest vari-
ability among the three Belgian PCV2 genotypes. Despite this
highest homology, the Belgian PCV2d genotype could be
Table 2. Information on PCV2 PCR-positive isolates collected in Belgium from 2009 to 2018.
No. Isolates (cases) Collection year Sample PCV2 titers (log10TCID50/g) Accession No. Genotype
1 09V003 2009 Mixed organs 4.7 MK005834 2b
2 09V005 2009 Lung 2.0 MK005831 2a
3 09V019 2009 Spleen 4.5 MK005835 2b
4 09v026 2009 Lymph node 5.5 MK005832 2a
5 09V042 2009 Lung þ lymph node 5.5 MK005836 2b
6 09V089 2009 Organs foetus Positivea MK005833 2a
7 09V117-1 2009 Lung 4.3 MK005837 2b
8 09V117-2 2009 Lung 5.5 MK005838 2b
9 09V118 2009 Spleen 4.7 MK005839 2b
10 09V141 2009 Lung 5.0 MK005840 2b
11 09V153 2009 Lymph node 5.5 MK005841 2b
12 09V178 2009 Lymph node 3.0 MK005842 2b
13 09V257 2009 Spleen 2.0 MK005843 2b
14 09V408 2009 Lung 3.2 MK005844 2b
15 09V410 2009 Kidney 2.0 MK005845 2b
16 09V448 2009 Lymph node 5.5 MK005865 2d-1
17 10V005 2010 Lymph node 4.7 MK005846 2b
18 10V008 2010 Lung 2.5 MK005847 2b
19 10V009 2010 Spleen þ lymph node 4.7 MK005866 2d-1
20 10V059 2010 Lymph node 2.5 MK005848 2b
21 10V139 2010 Lung 3.0 MK005849 2b
22 10V147 2010 Lymph node 4.5 MK005850 2b
23 10V149 2010 Lung þ lymph node 5.5 MK005867 2d-1
24 10V183 2010 Lymph node þ heart 2.0 MK005851 2b
25 10V232 2010 Lymph node 5.5 MK005852 2b
26 10V513 2010 Lung 2.5 MK005868 2d-1
27 10V532 2010 Spleen þ lung 2.0 MK005869 2d-1
28 10V542 2010 Lymph node 2.0 MK005870 2d-1
29 11V012 2011 Lymph Node 5.3 MK005853 2b
30 11V152 2011 Spleen 1.7 MK005854 2b
31 11V300 2011 Lung 5.5 MK005855 2b
32 11V519 2011 Lung Positivea MK005856 2b
33 12V001 2012 Organs foetus 2.8 MK005857 2b
34 12V042-1 2012 Mixed organs 4.5 MK005858 2b
35 12V042-2 2012 Mixed organs 4.5 MK005859 2b
36 12V042-3 2012 Mixed organs 4.5 MK005860 2b
37 13V067 2013 Lung 5.5 MK005861 2b
38 13V068 2013 Spleen 5.0 MK005862 2b
39 13V069 2013 Lymph node 5.5 MK005863 2b
40 13V071 2013 Spleen 5.0 MK005864 2b
41 18v047 2018 Serum Negative MH287045 2d-2
42 18v126 2018 Serum Negative MK005871 2d-2
43 18v152 2018 Serum Negative MK005872 2d-2
aPositive means that the sample was positive for virus isolation, but the corresponding virus titer was not recorded.
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separated into two subtypes. The ORF2 gene of 6 PCV2d-1 iso-
lates demonstrated 97.9–99.4 per cent nucleotide sequence and
97.0–99.1 per cent amino acid sequence identities whereas that
of three PCV2d-2 sequences had 97.7–100 per cent and 97.0–100
per cent identities.
3.4 Selection pressure analysis
Selection pressure on the capsid protein of Belgian PCV2
isolates was estimated. In the difference between non-
synonymous and synonymous substitution rates (dN-dS), the
cap gene was negative (1.575), indicating that the capsid of
Belgian PCV2 had evolved under purifying selection. This is in
accordance with previous studies where purifying selection was
identified in the cap gene (Olvera, Cortey, and Segale´s 2007;
Xiao, Halbur, and Opriessnig 2015). However, three codons
(positions 59, 131, and 191) were identified under positive
selection through the MEME (P< 0.1) and FUBAR approaches
(Post. Pr. > 0.9) (Table 4). Position 59 is a critical amino acid that
is part of the neutralizing epitope (Huang et al. 2011); position
131 is important for determining neutralization activity (Saha
et al. 2012a); and the mutation at position 191 may affect the
growth ability of PCV2 both in vitro and in vivo (Fenaux et al.
2004a).
3.5 Amino acid analysis of PCV2 cap sequences
The amino acid alignment of the capsid protein encoded by the
ORF2 gene was further conducted for the forty-three PCV2
strains in this study (Supplementary Fig. S1). Amino acid com-
parisons among the forty-three PCV2 isolates and twenty-one
reference strains revealed that a greater diversity was found in
three major regions (53–91, 121–136, and 169–217) and at three
major positions (151, 232, and 234). Moreover, certain amino
acids only appear in strains of one but not the other two geno-
types. For instance, ten amino acid residues (75N/K, 76L, 86T,
88K, 89I, 91I, 123I/V, 136Q, 190S/T, and 232N/K, indicated in red)
were only found in clusters of PCV2a isolates; fifteen (11K/R,
29F/L, 82K/P, 85H/G, 89L/R, 112P/T, 141S/Y, 169A/S, 188H/Q,
190A, 206V, 210D/G/E, 215G/I/V, 217L/M, and 222T/R, indicated
in orange) in PCV2b isolates, and twelve (10G/R, 53I, 59A/K/R,
68N, 130I/V, 134N, 169W/R/G, 188P/Q, 200P/T, 207H/Y, 215I, and
216A/T, indicated in green) in the clusters of PCV2d
(Supplementary Table S2). Among these variable amino acids,
Figure 1. Phylogenetic analysis of PCV2 isolates based on ORF2 sequences obtained in this study () together with the reference sequences from GenBank. The neigh-
bour-joining tree was constructed by molecular evolutionary genetics analysis (MEGA) software version 7.0. The PCV1 and PCV3 sequences provided an outgroup to
root the tree.
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some mutations were limited to a few strains, such as 11K/R
among PCV2b isolates, with K present in one out of thirty-one
PCV2b isolates and R in the remaining thirty strains. These
mutations seldom reflect the whole picture of PCV2 genotypic
evolution, and thus are of little importance.
Other mutations were present in all or at least the majority
of the strains of the genotype, such as 57V/I among PCV2b iso-
lates, with V present in two out of thirty-one PCV2b isolates and
one in the other twenty-nine strains. These mutations may rep-
resent the general evolutionary trace of that genotype, and is
thereby of great importance. Such mutations were selected and
presented in Table 5. Amino acids at these important mutation
sites were mapped on the corresponding 3D structure of the cap
protein of PCV2a (strain Fh17), PCV2b (strain 1206), and PCV2d
(strain K2) (Fig. 2). Different colour codes were used for different
amino acid sites, and the same colour was used for the same
amino acid site across the three different genotypes. On the in-
ner side of the cap protein where the cap protein interacts with
the viral genome, three mutations at positions 53 (F-F-I), 121 (S-
S-T), and 215 (V-V-I) were found on the b-sheet structure across
the three genotypes (PCV2a–PCV2b–PCV2d). These mutations
are conserved and less likely to induce any changes, since F, I,
and V belong to the hydrophobic amino acids, and S and T to
the polar amino acids. Because the amino acids of the inner
part of the cap protein that interact with the viral genome are
conserved, it became clear that the inner b-sheets are essential
in the PCV2 morphogenesis and stability of the structure.
Interestingly, most of the amino acid mutations were found on
the outside of the cap protein where the cap protein interacts
with the environment. On the upper part of the cap protein,
mutations were found in amino acids at positions 59, 206, and
63 that were very close to each other and formed a large surface
area (A/K/S for PCV2a, R/I/R for PCV2b, and A/K/R for PCV2d). It
is obvious that this area became more basic with the evolution
from PCV2a to PCV2b and PCV2d, due to the formation of a clus-
ter of basic polar amino acids (KþR). A single amino acid at po-
sition 169 (S-S-R) followed this trend as well. This indicated that
this area of the PCV2 capsid was evolving toward more positive
charges which may lead to a more efficient binding to the nega-
tively charged glycosaminoglycan (GAG) receptors. Another
large surface area where mutations were found was formed by
amino acids at positions 57, 68, and 134, which is V/A/T for
PCV2a, I/A/T for PCV2b, and V/N/N for PCV2d. Compared with
PCV2a and PCV2b, this area of PCV2d increased its polarity by
adding a second polar amino acid (NN) instead of a non-polar
amino acid (A, I, or V). In this way, a better environment is cre-
ated for receptor binding by hydrogen bonds. Similarly, a single
mutation of the amino acid at position 131 (I-T-T) also shifted
from a hydrophobic amino acid (I) to a polar one (T), which fit-
ted in this hypothesis as well. Together, this suggested that,
with mutations of amino acids at the upper part of the cap pro-
tein, PCV2 has evolved for a more efficient binding with GAGs.
Table 3. Per cent of nucleotide and amino acid sequence similarity of ORF2 among reference strains and PCV2 isolates in our study by pairwise
comparison.
Nucleotide (nt) and amino acid (aa) identities of strains (%)
Type C
(AF109398)
(PCV2a)
Isolates in
our study
(PCV2a)
1206
(EF990644)
(PCV2b)
Isolates in
our study
(PCV2b)
VC2002-K2
(EF990645)
(PCV2d-1)
Isolates in
our study
(PCV2d-1)
BDH
(HM038017)
(PCV2d-2)
PCR isolates
in our study
(PCV2d-2)
Type C (AF109398) (PCV2a) nt 100 95.2–97.5 93.5 91.9–94 92.3 91.2–92.3 92.1 92.1
aa 100 93.1–96.2 91.9 88.8–93.8 89.4 88.1–89.4 88.8 88.8
Isolates in our study (PCV2a) nt – 94.9–99.9 92.6–93.3 91.5–95.2 90.0–93.7 89.7–94.2 90.2–93.4 90.0–93.6
aa – 95.7–100 90.6–91.9 89.3–94.9 88.9–90.2 87.2–90.6 87.6–89.7 87.6–90.2
1206 (EF990644) (PCV2b) nt – – 100 98.3–99.6 93.6 93.4–94.6 94.3 94.2–94.3
aa – – 100 95.3–99.6 93.2 93.2–94.4 93.6 93.6
Isolates in our study (PCV2b) nt – – – 95.2–100 92.3–94.7 92.6–95.4 93.2–95.4 93.0–95.4
aa – – – 94.0–100 91.5–94.9 91.0–96.2 91.9–95.3 91.9–95.3
VC2002-K2 (EF990645) (PCV2d-1) nt – – – – 100 97.9–99.3 98 97.9
aa – – – – 100 97.4–99.1 98.3 97.9–98.3
Isolates in our study (PCV2d-1) nt – – – – – 97.9–99.4 97.9–98.4 97.7–98.3
aa – – – – – 97.0–99.1 97.4–99.1 97.0–100
BDH (HM038017) (PCV2d-2) nt – – – – – – 100 99.9
aa – – – – – – 100 99.6–100
PCR isolates in our
study (PCV2d-2)
nt – – – – – – – 97.7–100
aa – – – – – – – 97.0–100
Table 4. Selection pressure analysis of cap protein of PCV2 using SLAC, FEL, MEME, and FUBAR methods.
Codon SLAC FEL MEME FUBAR
dN–dS P-value dN–dS P-value bþ P-value dN–dS Post. Pr.
59 3.95 0.348 0.272 0.898 184.84 0.00 14.118 0.913
131 6.22 0.151 2.393 0.159 3.47 0.09 6.623 0.973
191 6.74 0.0869 4.695 0.098 7.04 0.02 5.287 0.984
Codon with P-value < 0.1 in SLAC, FEL, and MEME methods, or with Post. Pr.  0.9 in FUBAR method (showed in bold), was considered under positive selection.
Condon: positively selected sites (AA), bþ: the MLE of the unconstrained b non-synonymous rate, and Post. Pr.: posterior probability.
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On the lower part of the cap protein, there were three large sur-
face areas which were formed by groups of mutated amino
acids among three genotypes. The first one (V/D/S for PCV2a, I/
N/A for PCV2b, and L/N/T for PCV2d) was formed by amino acids
at positions 80, 77, and 190; the second one (V/S/I for PCV2a, L/S/
V for PCV2b, and L/T/V for PCV2d) was formed by amino acids at
positions 80, 90, and 91; and the last one (T/K/I for PCV2a, S/P/R
for PCV2b, and S/P/L for PCV2d) was formed by amino acids at
positions 86, 88, and 89. Mutations in the former two areas were
generally conserved, since the mutated amino acids were
replaced by ones with similar biochemical properties; muta-
tions in the last area resulted in a loss of the basic positively
charged polar amino acid. This means that there were less
changes in the lower part of the capsid protein. On the ‘tail’ part
of the cap protein, an amino acid at position 232 changed from
a basic polar K for PCV2a to a polar neutral N for both PCV2b/d.
For PCV2d, there was an extra basic polar amino acid K at posi-
tion 234, while this amino acid K at position 234 was absent for
PCV2a/b. Moreover, the surface of the basic polar amino acid K
at position 234 was very close to that of the polar amino acid N
at position 232 for PCV2d. It was inferred that the polar amino
acid N at position 232 could extend further from the capsid sur-
face, thus projecting the neighbouring positively charged K to
the outer environment to search for/enhance the initial, non-
specific interaction of the virus with negatively charged hep-
aran/chondroitin sulphate on the cell membrane during PCV2
infection.
In conclusion, the amino acid motifs were multi-variate in
the cap sequences of these forty-three Belgian PCV2 isolates.
From an evolutionary point of view, most amino acid mutations
were found on the outer surface of the cap protein, with the up-
per and tail parts of the cap protein consisting of more basic
amino acid clusters and the lower part being more conserved
but somewhat less basic; the amino acids at the inner part were
conserved to interact with the viral genome and maintain the
stability of the PCV2 virion.
4. Discussion
In Belgium, the first retrospective serological study was per-
formed on archived samples from nursery pigs, fattening pigs,
and young sows by IPMA, showing that the presence of PCV2
dates back to 1985 (Labarque et al. 2000); another detailed sero-
logical survey of PCV2 antibodies in domestic and feral pig pop-
ulation later in Belgium showed the evidence of PCV2 infections
in 1969 (Sanchez, Nauwynck, and Pensaert 2001a). Apart from
these serological studies, little genetic information of PCV2
strains in Belgium was available. In the present study, we exam-
ined the molecular epidemiology and evolution of PCV2 strains
circulating in Belgium, by evaluating the frequency of the virus
detection, the genotype distribution, and their heterogeneity
from archived diagnostic samples from 2009 till 2018. This study
is the first report on the molecular characterization of Belgian
PCV2 strains.
Table 5. Genotype-specific amino acid residues in the cap protein of forty-three Belgian PCV2 isolates (PCV2a: three isolates; PCV2b: thirty-one
isolates; PCV2d-1: six isolates; and PCV2d-2: three PCR isolates) and twenty-one reference strains (PCV2a: eight strains; PCV2b: seven strains;
PCV2d-1: two strains; and PCV2d-2: four strains).
Position PCV2a PCV2b PCV2d-1 PCV2d-2
Isolates in
our study
Reference
strainsa
Isolates in
our study
Reference
strains
Isolates in
our study
Reference
strains
Isolates in
our study
Reference
strains
53 F F F F I I I I
57 V V 2V/29I 3V/4I V V V V
59 R 2R/6A R R 1A/1R/4K A K K
63 1S/2T 1S/3R/4T 1T/9R/21K 3K/4R R R R R
68 A A A A N N N N
77 D 1N/7D 1D/30N N N N N N
80 V 1L/7V 1V/30L L L L L L
86 T T S S S S S S
88 K K P P P P P P
89 I I 1L/30R R L L L L
90 S S 1T/30S S T T T T
91 I 1V/7I V V V V V V
121 S 3S/5T 1T/30S S T T T T
131 1I/2P 1I/3T/4P 12P/19T T T T T T
134 T 1P/7T T T N N N N
151 1P/2T 1T/7P T 1P/6T 1T/5P P T T
169 1S/2G S 1A/30S S 1W/5R R 1R/2G 2R/2G
190 1S/2T S A A T T T T
206 K K 1V/30I I I 1K/1I I I
210 D D 1D/2G/28E E 2D/4E D D D
215 V V 1G/1I/29V V I I I I
232 K 1N/6K N N N N N N
234 – – – – K K K K
PCV2a reference sequences: AY556474, AF109398, AY180396, AF201308, AY322004, AJ293868, AF055392, AB072301; PCV2b reference sequences: EF990646, EF990644,
AY916791, AY691169, AY484407, AY424405, AY321984; PCV2d reference sequences: EF990645, AB462384 (PCV2d-1); KJ187306, JX535296, JX519293, HM038017. –, Dashes
indicate amino acid residues at this position are absent among these PCV2 genotypes.
aOne reference strain PCV2a-AF109398-Canada1998 has only a partial cap sequence (positon 1-168) deposited on GenBank.
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Figure 2. Three-dimensional mapping of critical amino acids presented in Table 5 on capsid of PCV2a, PCV2b, and PCV2d. The 3D structures of capsid were generated
using I-TASSER server and displayed with PyMOL.
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Despite the early presence of PCV2 in 1969, Belgian farms
were rarely affected by PMWS-related problems. In three
Belgian farms with a history of PMWS, the percentage of PMWS-
positive piglets was very low (2%) compared to those described
in the UK (up to 22%), USA (up to 15%), France (11%), and Spain
(up to 30%) (Kiupel et al. 1998; Gresham et al. 2000; Madec et al.
2000; Segales and Domingo 2002; Meerts et al. 2004). Until now,
only four Belgian PCV2 strains were isolated from PMWS-
affected piglets. Strains 1206 and VC2002-K39 were identified
as PCV2b, strain VC2002-K2 as PCV2d-1 and strain 4D4 as a re-
combinant strain of VC2002-K2 and VC2002-K39 (Lefebvre et al.
2009). The successful application of vaccination, improved bio-
safety measures, and better hygiene may explain the decreased
number of samples that were sent in our laboratory for PCV2
diagnosis from 2014 to 2018. Another reason could be that PCV2
diagnosis became a routine in a number of laboratories across
Belgium during that period, resulting samples being sent to
other laboratories.
In this study, three PCV2 genotypes (PCV2a, PCV2b, and
PCV2d) were identified in Belgium. PCV2b was the predominant
genotype from 2009 till 2013. The three isolates from 2018
belonged to genotype PCV2d. Samples from 2014 to 2017 were
negative for virus isolation and thus were not submitted for fur-
ther PCR analysis. Only three cases of PCV2a were detected ex-
clusively in 2009 in our study in Belgium, while on a worldwide
scale PCV2a was the most dominant genotype in pig population
before 2003 (Xiao, Halbur, and Opriessnig 2015). During the pe-
riod of 2003–4, a global shift occurred from genotype 2a to 2b.
This agrees with the predominance of PCV2b from 2009 till 2013
in Belgium. In 2018, PCV2d, especially PCV2d-2, was the only cir-
culating subtype in Belgium in our study. The emergence and
spread of PCV2d-2, which appears to be replacing PCV2b, has
been suggested in several studies (Xiao, Halbur, and Opriessnig
2015; Franzo et al. 2016). PCV2d-1 was only found in 2009 (1/6)
and 2010 (5/6) in Belgium. This is in line with the global trend in
the identification of PCV2d-1 between 1999 and 2011 and
confirms the proposal that PCV2d-1 is a possible ancestor of
PCV2d-2 (Xiao, Halbur, and Opriessnig 2015). The emergence of
PCV2d-1 concurred with the spread of PCV2b, indicating that
PCV2b and PCV2d bifurcated early and evolved independently
in the pig population (Xiao, Halbur, and Opriessnig 2015). These
findings generally indicate a genotype shift from PCV2a to
PCV2b and from PCV2d-1 to PCV2d-2. The limited timeframe of
our study and the absence of PCV2 genetic data between 2014
and 2017, made it difficult to determine the exact genetic
changes in Belgium during that period.
Selection pressure plays a critical role in evolutionary
biology by shaping genetic variation. The high mutation rate of
PCV2, which is closer to that of a single-stranded RNA virus, can
enhance the frequency of selection, as well as the rapid emer-
gence of novel PCV2 genotypes. In our study, we identified three
codons (positions 59, 131, and 191) in the capsid protein of
Belgian PCV2 under positive selection pressure. Positions 59 and
191 are crucial in neutralizing activities, while the position 131
is related to the growth ability of PCV2. Broad vaccination,
which was used to control numerous PCVADs, might contribute
to the alteration of antigenic properties. Research on the role of
vaccination in PCV2 evolution is extremely challenging because
of the difficulty in recruiting a large number of farms where
vaccination has not been applied despite PCV2 circulation.
However, it is interesting to note that the first genotype shift
from PCV2a to PCV2b during the period of 2003–4 predates the
vaccination against PCV2 using PCV2a-type commercial vaccines
(first registration in 2007; CircovacVR , Merial). This genotype shift/
evolution is probably mainly driven by infection immunity which
is present on all farms. Although the ongoing genotype shift from
PCV2b to PCV2d occurs in the background of extensive vaccina-
tion with the PCV2a-type vaccines, PCV2 infections still occur
and induce a strong population immunity. Vaccination did not
reduce the variability of PCV2 strains in vaccinated herds (Reiner,
Hofmeister, and Willems 2015). As a result, it is likely that
population immunity against circulating wild-type PCV2 viruses
is the main driving force behind the genotypic evolution.
Since the PCV2 capsid protein is immunogenic, mutations on
the capsid protein may explain the direction of PCV2 genotypic
evolution. Mapping genotype-specific amino acids on the 3D
structure of the cap protein of different genotypes is of great in-
terest. It helps to identify the real locations of amino acids on the
cap protein, thus revealing the possible effect of amino acid
mutations on the structure of the virion and on the interaction of
virions with the environment (e.g. receptors). In the current
study, the amino acids on the inner part of the cap protein (where
the cap protein interacts with the viral genome) were conserved
to maintain the stability of PCV virion, and most amino acid
mutations were found on the surface of the cap protein (where
the cap protein interacts with the environment). Mutations on
the upper part of the cap protein consisted of more basic amino
acid clusters and the lower part more conserved but somewhat
less basic (Fig. 2). The tail was extended with one amino acid and
remained basic. It is likely that the capsid protein has mutated to
escape from the host immunity, evolving to bind more strongly
to its GAG receptors. This may explain the grouping of basic
amino acids in an area composed of the ‘head’ of one capsomere
and the ‘tail’ of the neighbouring capsomere and the longer
extended basic ‘tail’ (Fig. 3). It appears that PCV2d has formed an
extruding part to the cap protein, which improves the efficiency
of binding of the virus to the target cell.
Comparison of the complete ORF2 sequences of forty-three
Belgian PCV2 isolates revealed 89.7–100 per cent nucleotide ho-
mology and 88.5–100 per cent amino acid sequence identity.
Amino acid comparisons showed that a greater diversity was
found in the regions 53–91, 121–136, and 169–217 and at the
positions 151, 232, and 234. Similar non-conserved regions have
been demonstrated in another report (Wei et al. 2013). These
regions contain immunorelevant epitopes (residues 65–87, 113–
139, and 193–207) identified using pepscan analysis (Mahe et al.
2000). Frequent mutations in these regions may change the an-
tigenic features of PCV2 and help the virus to evade the immune
response, thus promoting virus propagation under field condi-
tions. Specifically, position 59 is a critical amino acid that is part
of the neutralizing epitope (Huang et al. 2011); positions 131 and
190 are important for determining neutralization activity (Saha
et al. 2012a); region 163–180 is suggested as a decoy epitope
resulting in the production of non-neutralizing antibodies
against PCV2 (Trible et al. 2011, 2012). Position 233 is critical in
maintaining effective binding between the epitope and anti-
body, which is conserved among all genotypes in our study
(Shang et al. 2009). Interestingly, a pair of signature motifs in
the ORF2 (aa position 86–91) of PCV2 which was described to dis-
tinguish viruses of genotype 2a (peptide sequence 86TNKISI91)
from strains of genotype 2b (86SNPRSV91), can also distinguish
viruses of genotype 2d (86SNPLTV91) in our study (Cheung et al.
2007; Wei et al. 2013). Thus, amino acids in region 86–91 can
serve as a ‘genetic marker’ to distinguish these three genotypes.
In this study, only the tissue samples from which virus was
isolated were subjected to further PCR analysis (except for the
serum samples in 2018). We believe that virus isolation is the
‘gold standard’ method to demonstrate that PCV2 is related to
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disease, based on the fact that DNA of circoviruses is detected
everywhere nowadays and that this DNA is not always associ-
ated with viable virus. For instance, the contaminating PCV,
which was detected in a porcine-derived commercial pepsin
product by PCR, was confirmed to be non-infectious as demon-
strated by both in vitro and in vivo infection experiments
(Fenaux et al. 2004b). The PCV DNA detected in some rotavirus
vaccines by qPCR consisted of small fragments of PCV genetic
material since the full length or partial amplicons of PCV could
not be amplified by conventional PCR (Esona et al. 2014). PCV2
DNA was detected in water samples in Brazil, farm air in
Canada, house flies in UK (Verreault et al. 2010; Blunt et al. 2011;
Garcia et al. 2012). Even in soil, PCV2 genome components were
demonstrated (Kim et al. 2008). In the USA, 70 per cent of the
store-bought pork products contain PCV sequences. This
resulted in the detection of PCV in stool samples from adults in
the USA (5%) possibly due to the dietary consumption of PCV-
infected pork (Li et al. 2010). Interestingly, previous work from
our laboratory demonstrated that monocytic cells, known as
scavenger cells and being responsible for cleaning up foreign
material in the body, can indeed take up PCV2 virions and disin-
tegrate viral capsids, but have problems with degrading/digest-
ing PCV2 DNA (Wei et al. 2018). The difficult-to-degrade
property of PCV2 genome may explain the ubiquitous presence
of the viral DNA. Taken together, it is clear that the detection of
PCV2 genetic material does not automatically mean that the
sample contains complete, viable, and infectious PCV2 virions.
This important yet overlooked information alerts us on the use
of the PCR, especially the sensitive qPCR for diagnostic pur-
poses. Normally the advisable product length of qPCR is around
150–200 bp, which means only a small part of the viral genome
is amplified. Can one state that pigs are positive for PCV2 based
on the detection of such small fragments of the PCV2 genome?
As to the question of whether pigs should be considered as
positive for PCV2 based on the detection of such small
fragments of the PCV2 genome, we feel that virus should be
successfully isolated, or at least the full length of PCV2 genome
amplified by conventional PCR, together with observations of
PCVAD clinical and pathological manifestations from pigs, be-
fore PCV2 should be considered as contributing to the clinical
disease observed.
In conclusion, we demonstrated that at least three geno-
types (PCV2a, PCV2b, and PCV2d) circulated in Belgium from
2009 till 2018, and that PCV2 evolved from PCV2a to PCV2b and
from PCV2d-1 to PCV2d-2. Mapping PCV2 genotype-specific
amino acids on the 3D structure of the capsid protein revealed
that most of the mutations were on the outside of the cap pro-
tein, with a few conserved mutations on the inner side of the
protein. Mutations on the upper and tail parts of the capsid pro-
tein evolved toward a more efficient binding to GAGs, while the
lower part of the protein was relatively conserved. Additional
epidemiological studies, including a retrospective analysis of vi-
rus circulation in Belgium before 2009, along with more continu-
ous up-to-date surveillance, are needed to better understand
the epidemic and evolutionary dynamics of PCV2 in Belgium,
and to see how the situation in Belgium conforms to what is
known about the global evolution of PCV2.
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Figure 3. Hypothetical model on the evolutionary amino acid mutations on the ‘head’ and ‘tail’ of the cap protein. (A) Front side: Surface mapping of amino acid
mutations on the head (positions 59, 206, and 63) and tail (positions 232 and 234) of the cap protein across three genotypes. (B) Three subunits forming a trimer, with
indications of the changes mentioned in (A). For PCV2a-Fh17 and PCV2b-1206, the head of one capsomere is close to the tail of the neighbouring capsomere; while for
PCV2d-K2, the head of one capsomere is apart from the tail of the neighbouring capsomere, and both the head and tail extrude further from the capsid surface. The tri-
mer was generated by SYMMDOCK server (Schneidman et al. 2005). The 3D structures of capsid were generated using I-TASSER server and displayed with PyMOL.
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